Work for Catabasis Pharmaceuticals, Inc.?

Claim Your Profile

Catabasis Pharmaceuticals, Inc. Logo Image

Catabasis Pharmaceuticals, Inc.

Catabasis Pharmaceuticals, Inc. Banner Image

About Catabasis Pharmaceuticals, Inc.

11-50 Employees
Based in Boston, Massachusetts

At Catabasis Pharmaceuticals, their mission is to bring hope and life-changing therapies to patients and their families. Their lead program is edasalonexent, an NF-kB inhibitor in Phase 3 development for the treatment of Duchenne muscular dystrophy.

Ticker:
CATB
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol